What is the Size of Clinical Trial Imaging Market?
The clinical trial imaging market size is forecast to increase by USD 551.3 million and is estimated to grow at a CAGR of 7.5% between 2023 and 2028. The market is experiencing significant growth due to the increasing investment in drug development for chronic diseases. Imaging techniques, such as Computed Tomography (CT), play a crucial role in clinical trials by providing valuable data for drug efficacy and safety assessments. Patient comfort is a key trend in this market, as Breast imaging technologies are being developed to minimize patient discomfort and improve the overall trial experience. Data management services are also gaining importance to ensure accurate and efficient handling of imaging data. Strict regulations, however, pose a challenge to market growth, requiring strong data security and compliance measures. Overall, the market is expected to continue its expansion, driven by the need for advanced imaging technologies to support the development of new treatments.
Request Free Market Sample
Market Segment
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
- Modality
- Computed tomography
- Magnetic resonance imaging
- Ultrasound
- Positron emission tomography
- Others
- End-user
- Contract research organization
- Pharmaceutical and biotechnology companies
- Research and academic institutes
- Medical device manufacturers
- Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
Which is the Largest Segment Driving Market Growth?
The computed tomography segment is estimated to witness significant growth during the forecast period. The market is experiencing notable progressions, with a notable focus on the computed tomography (CT) segment. CT imaging is a vital imaging modality in clinical trials due to its ability to generate detailed cross-sectional images of the body, which are crucial for precise diagnosis and tracking of various medical conditions, including cancer. The rising prevalence of chronic diseases and the demand for early and precise diagnosis have boosted the importance of high-resolution imaging technologies.
Get a glance at the market share of various regions Download the PDF Sample
The computed tomography segment was the largest segment and valued at USD 317.40 million in 2018. CT scans are indispensable in evaluating disease progression and treatment effectiveness in clinical trials. Furthermore, technological innovations in CT imaging, such as photon counting computed tomography (PCCT), are expanding the capabilities of clinical trial imaging. Magnetic Resonance Imaging (MRI), Echocardiography, Nuclear Medicine, Positron Emission Tomography (PET), and X-ray are other significant imaging modalities in clinical trials. MRI offers superior soft tissue contrast and is widely used in neurology, oncology, and cardiology trials. Hence, such factors are fuelling the growth of this segment during the forecast period.
Which Region is Leading the Market?
For more insights on the market share of various regions Request Free Sample
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The North American market is a significant contributor to the global industry, fueled by substantial investments from both private and public sectors. This region's market dynamics are shaped by strategic investments, technological advancements, and a strong focus on innovation in the therapeutic area of chronic conditions.
How do Technavio's company ranking index and market positioning come to your aid?
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Clario: The company offers clinical trial imaging for ophthalmology, cardiovascular, neuroscience and others.
Technavio provides the ranking index for the top 20 companies along with insights on the market positioning of:
- Alimentiv Inc
- ARANZ Medical Ltd
- Aster Medical Imaging LLC
- Charles River Laboratories International Inc.
- ICON plc
- Image Core Lab Pvt Ltd
- IXICO plc
- Median Technologies SA
- Medidata
- Medpace Holdings Inc.
- Navitas Life Sciences
- Octalsoft
- QMENTA Imaging SL
- QUANTIFICARE
- THIRONA
- Vista Diagnostics Ltd
- Voiant
- WCG Clinical Inc.
- Yunu, Inc.
Explore our company rankings and market positioning Request Free Sample
How can Technavio Assist you in Making Critical Decisions?
What is the Market Structure and Year-over-Year growth of the Market?
|
Market structure
|
Fragmented
|
|
YoY growth 2023-2024
|
7.0
|
Market Dynamic
The integration of medical imaging technologies in clinical trials has revolutionized the biotechnology and pharmaceutical industries. By providing valuable insights into various health conditions, these advanced imaging techniques contribute significantly to the development of new therapeutics and treatments. In the realm of clinical trials, imaging technologies play a pivotal role in assessing the efficacy and safety of new drugs and therapies. Biotechnology and pharmaceutical companies increasingly rely on these technologies to gather data on disease progression, treatment response, and potential side effects. Image analysis software, fueled by artificial intelligence (AI) and machine learning algorithms, is a crucial component of this process. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the Primary Factors Driving the Market Growth?
Growing investment in drug discovery is notably driving market growth. The market is driven by the escalating investment in pharmaceutical research and development. These funds are vital for advancing research and development efforts in the biopharmaceutical sector, enabling companies to execute extensive clinical trials.
Furthermore, clinical trials are indispensable for assessing the safety and efficacy of new drugs and therapies. Imaging technologies, including medical imaging and image analysis software, play a pivotal role in clinical trials. These advanced tools facilitate the monitoring of disease progression, treatment response, and adverse effects. The increasing adoption of virtual imaging trials further enhances the efficiency and accuracy of clinical trials, ultimately leading to the development of innovative treatments for various medical conditions. Thus, such factors are driving the growth of the market during the forecast period.
What are the Significant Trends being Witnessed in the Market?
Partnerships and collaborations is the key trend in the market. The market in is experiencing a notable trend towards collaborative partnerships, which are fostering innovation and streamlining the clinical trial process. These strategic alliances are essential for merging expertise, broadening capabilities, and delivering comprehensive imaging solutions tailored to the dynamic requirements of drug development for chronic diseases.
This collaboration aims to heighten the precision and productivity of clinical trials in the pulmonary domain, offering more accurate imaging data and ultimately enhancing overall trial success. By combining their respective strengths, these partners can effectively address the complexities of clinical research and contribute to the advancement of healthcare solutions. Thus, such trends will shape the growth of the market during the forecast period.
What are the Major Market Challenges?
Strict regulations is the major challenge that affects the growth of the market. The market is experiencing notable advancements driven by the integration of innovative technologies such as Artificial Intelligence (AI) and Machine Learning (ML) into Imaging Modalities. These technologies are revolutionizing Oncology imaging solutions by enhancing diagnostic accuracy and enabling early detection of diseases.
As Imaging Solutions become more sophisticated, they will play a crucial role in advancing healthcare and facilitating the development of new treatments. Key players in the market include companies specializing in Imaging Modalities, AI and ML algorithms, and operational Imaging Services. In summary, the market is witnessing significant growth due to technological advancements and the increasing adoption of operational Imaging Services. Hence, the above factors will impede the growth of the market during the forecast period
Exclusive Customer Landscape
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Market Analyst Overview
The market for medical imaging in the biotechnology and pharmaceutical industries is experiencing significant growth due to the increasing role of imaging technologies in drug development. Image analysis software and virtual imaging trials are becoming essential tools in this process, with advancements in artificial intelligence and machine learning enabling more accurate and efficient analysis. Imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI, echocardiography, nuclear medicine, positron emission tomography (PET), x-ray, ultrasound, optical coherence tomography, and various imaging techniques are used extensively in clinical trials for therapeutic areas like oncology, neurology, endocrinology, cardiology, dermatology, hematology, and others.
Moreover, patient comfort and safety are key considerations, with imaging solutions providing operational imaging services to ensure optimal conditions. Data management services are also crucial in managing the large volumes of imaging data generated during clinical trials. Medical device companies and healthcare providers are collaborating to provide therapeutic expertise and imaging technology to support the development of new treatments for chronic conditions. Molecular imaging and diffusion-weighted imaging (DWI) are also gaining popularity in clinical trials for their ability to provide valuable insights into the biological processes underlying various diseases.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
211
|
|
Base year
|
2023
|
|
Historic period
|
2018 - 2022 |
|
Forecast period
|
2024-2028
|
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 7.5%
|
|
Market growth 2024-2028
|
USD 551.3 million
|
|
Regional analysis
|
North America, Europe, Asia, and Rest of World (ROW)
|
|
Performing market contribution
|
North America at 38%
|
|
Key countries
|
US, China, Germany, UK, and Japan
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled
|
Alimentiv Inc, ARANZ Medical Ltd, Aster Medical Imaging LLC, Charles River Laboratories International Inc., Clario, ICON plc, Image Core Lab Pvt Ltd, IXICO plc, Median Technologies SA, Medidata, Medpace Holdings Inc., Navitas Life Sciences, Octalsoft, QMENTA Imaging SL, QUANTIFICARE, THIRONA, Vista Diagnostics Ltd, Voiant, WCG Clinical Inc., and Yunu, Inc.
|
|
Market dynamics
|
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, AI impact on market trends, COVID -19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period
|
|
Customization purview
|
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
|
Download PDF Sample
What are the Key Data Covered in this Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the market in focus to the parent market
- Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of market companies
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Modality
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global Clinical Trial Imaging Market 2018 - 2022
- Historic Market Size - Data Table on Global Clinical Trial Imaging Market 2018 - 2022 ($ million)
- 5.2 Modality segment analysis 2018 - 2022
- Historic Market Size - Modality Segment 2018 - 2022 ($ million)
- 5.3 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
- 5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
- 6.1 Impact of Artificial Intelligence (AI) on global clinical trial imaging market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Modality
- 8.1 Market segments
- Chart on Modality - Market share 2023-2028 (%)
- Data Table on Modality - Market share 2023-2028 (%)
- 8.2 Comparison by Modality
- Chart on Comparison by Modality
- Data Table on Comparison by Modality
- 8.3 Computed tomography - Market size and forecast 2023-2028
- Chart on Computed tomography - Market size and forecast 2023-2028 ($ million)
- Data Table on Computed tomography - Market size and forecast 2023-2028 ($ million)
- Chart on Computed tomography - Year-over-year growth 2023-2028 (%)
- Data Table on Computed tomography - Year-over-year growth 2023-2028 (%)
- 8.4 Magnetic resonance imaging - Market size and forecast 2023-2028
- Chart on Magnetic resonance imaging - Market size and forecast 2023-2028 ($ million)
- Data Table on Magnetic resonance imaging - Market size and forecast 2023-2028 ($ million)
- Chart on Magnetic resonance imaging - Year-over-year growth 2023-2028 (%)
- Data Table on Magnetic resonance imaging - Year-over-year growth 2023-2028 (%)
- 8.5 Ultrasound - Market size and forecast 2023-2028
- Chart on Ultrasound - Market size and forecast 2023-2028 ($ million)
- Data Table on Ultrasound - Market size and forecast 2023-2028 ($ million)
- Chart on Ultrasound - Year-over-year growth 2023-2028 (%)
- Data Table on Ultrasound - Year-over-year growth 2023-2028 (%)
- 8.6 Positron emission tomography - Market size and forecast 2023-2028
- Chart on Positron emission tomography - Market size and forecast 2023-2028 ($ million)
- Data Table on Positron emission tomography - Market size and forecast 2023-2028 ($ million)
- Chart on Positron emission tomography - Year-over-year growth 2023-2028 (%)
- Data Table on Positron emission tomography - Year-over-year growth 2023-2028 (%)
- 8.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 8.8 Market opportunity by Modality
- Market opportunity by Modality ($ million)
- Data Table on Market opportunity by Modality ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Contract research organization - Market size and forecast 2023-2028
- Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
- Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
- Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
- Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
- 9.4 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
- Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- 9.5 Research and academic institutes - Market size and forecast 2023-2028
- Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
- Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
- Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%)
- Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%)
- 9.6 Medical device manufacturers - Market size and forecast 2023-2028
- Chart on Medical device manufacturers - Market size and forecast 2023-2028 ($ million)
- Data Table on Medical device manufacturers - Market size and forecast 2023-2028 ($ million)
- Chart on Medical device manufacturers - Year-over-year growth 2023-2028 (%)
- Data Table on Medical device manufacturers - Year-over-year growth 2023-2028 (%)
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 11.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 11.12 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 11.13 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 11.14 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 11.15 Australia - Market size and forecast 2023-2028
- Chart on Australia - Market size and forecast 2023-2028 ($ million)
- Data Table on Australia - Market size and forecast 2023-2028 ($ million)
- Chart on Australia - Year-over-year growth 2023-2028 (%)
- Data Table on Australia - Year-over-year growth 2023-2028 (%)
- 11.16 Brazil - Market size and forecast 2023-2028
- Chart on Brazil - Market size and forecast 2023-2028 ($ million)
- Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
- Chart on Brazil - Year-over-year growth 2023-2028 (%)
- Data Table on Brazil - Year-over-year growth 2023-2028 (%)
- 11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Charles River Laboratories International Inc.
- Charles River Laboratories International Inc. - Overview
- Charles River Laboratories International Inc. - Business segments
- Charles River Laboratories International Inc. - Key offerings
- Charles River Laboratories International Inc. - Segment focus
- SWOT
- 14.5 Clario
- Clario - Overview
- Clario - Product / Service
- Clario - Key offerings
- SWOT
- 14.6 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
- 14.7 Image Core Lab Pvt Ltd
- Image Core Lab Pvt Ltd - Overview
- Image Core Lab Pvt Ltd - Product / Service
- Image Core Lab Pvt Ltd - Key offerings
- SWOT
- 14.8 IXICO plc
- IXICO plc - Overview
- IXICO plc - Product / Service
- IXICO plc - Key news
- IXICO plc - Key offerings
- SWOT
- 14.9 Median Technologies SA
- Median Technologies SA - Overview
- Median Technologies SA - Product / Service
- Median Technologies SA - Key offerings
- SWOT
- 14.10 Medidata
- Medidata - Overview
- Medidata - Product / Service
- Medidata - Key offerings
- SWOT
- 14.11 Medpace Holdings Inc.
- Medpace Holdings Inc. - Overview
- Medpace Holdings Inc. - Product / Service
- Medpace Holdings Inc. - Key offerings
- SWOT
- 14.12 Navitas Life Sciences
- Navitas Life Sciences - Overview
- Navitas Life Sciences - Product / Service
- Navitas Life Sciences - Key offerings
- SWOT
- 14.13 QMENTA Imaging SL
- QMENTA Imaging SL - Overview
- QMENTA Imaging SL - Product / Service
- QMENTA Imaging SL - Key offerings
- SWOT
- 14.14 QUANTIFICARE
- QUANTIFICARE - Overview
- QUANTIFICARE - Product / Service
- QUANTIFICARE - Key offerings
- SWOT
- 14.15 THIRONA
- THIRONA - Overview
- THIRONA - Product / Service
- THIRONA - Key offerings
- SWOT
- 14.16 Vista Diagnostics Ltd
- Vista Diagnostics Ltd - Overview
- Vista Diagnostics Ltd - Product / Service
- Vista Diagnostics Ltd - Key offerings
- SWOT
- 14.17 Voiant
- Voiant - Overview
- Voiant - Product / Service
- Voiant - Key offerings
- SWOT
- 14.18 WCG Clinical Inc.
- WCG Clinical Inc. - Overview
- WCG Clinical Inc. - Product / Service
- WCG Clinical Inc. - Key offerings
- SWOT
15 Appendix
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
Get the report (PDF) sent to your email within minutes.
